InvestSMART

Black Cat Syndicate Limited (ASX: BC8) - Announcements

Current share price for BC8 : $0.585 0.11 (15.83%)+

ASX company news and announcements for Black Cat Syndicate Limited (BC8) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Black Cat Syndicate Limited (BC8) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Black Cat Syndicate Limited (BC8), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Black Cat Syndicate Limited (BC8)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$426 Gabbro Veins continue to swarm - 3.42m @ 16.21g/t Au 6 Feb 2023 8:18AM $0.405 $0.585 risen by 44.44%
$426 Appointment of Chief Financial Officer 3 Feb 2023 4:28PM $0.405 $0.585 risen by 44.44%
$426 Quarterly Activities Report and Appendix 5B 31 Jan 2023 7:54AM $0.400 $0.585 risen by 46.25%
$426 Change of Director's Interest Notice 27 Jan 2023 4:44PM $0.400 $0.585 risen by 46.25%
$426 Application for quotation of securities - BC8 27 Jan 2023 4:44PM $0.400 $0.585 risen by 46.25%
$426 Exercise of Options and Cleansing Notice 27 Jan 2023 4:42PM $0.400 $0.585 risen by 46.25%
$426 Application for quotation of securities - BC8 27 Jan 2023 9:47AM $0.390 $0.585 risen by 50%
$426 Completion of Placement and Cleansing Notice 27 Jan 2023 9:47AM $0.390 $0.585 risen by 50%
$426 Application for quotation of securities - BC8 20 Jan 2023 5:24PM $0.425 $0.585 risen by 37.65%
$426 Exercise of Options and Cleansing Notice 20 Jan 2023 5:22PM $0.425 $0.585 risen by 37.65%
$426 Proposed issue of securities - BC8 19 Jan 2023 9:43AM $0.450 $0.585 risen by 30%
$426 Placement to Accelerate Drilling and Restart Plans 19 Jan 2023 9:43AM $0.450 $0.585 risen by 30%
$426 Trading Halt 17 Jan 2023 9:33AM $0.450 $0.585 risen by 30%
$426 One of Australia's highest-grade deposits - 356koz @ 14.6g/t 16 Jan 2023 8:21AM $0.380 $0.585 risen by 53.95%
$426 Notification of cessation of securities - BC8 13 Jan 2023 7:15PM $0.380 $0.585 risen by 53.95%
$426 Cancellation of Options and Performance Rights 13 Jan 2023 7:14PM $0.380 $0.585 risen by 53.95%
$426 Gabbro Vein Results Continue to Deliver - Paulsens 13 Jan 2023 8:17AM $0.375 $0.585 risen by 56%
$426 Application for quotation of securities - BC8 6 Jan 2023 7:02PM $0.380 $0.585 risen by 53.95%
$426 Application for quotation of securities - BC8 6 Jan 2023 7:01PM $0.380 $0.585 risen by 53.95%
$426 Issue of Shares and Cleansing Notice 6 Jan 2023 7:00PM $0.380 $0.585 risen by 53.95%
$426 Exercise of Options and Cleansing Notice 30 Dec 2022 5:26PM $0.355 $0.585 risen by 64.79%
$426 Application for quotation of securities - BC8 30 Dec 2022 5:25PM $0.355 $0.585 risen by 64.79%
$426 2022 - Year in Review 30 Dec 2022 8:22AM $0.340 $0.585 risen by 72.06%
$426 High-Grade Initial Gabbro Vein Results - Paulsens 22 Dec 2022 9:35AM $0.365 $0.585 risen by 60.27%
$426 Assay Results Fill the Gap at Coyote with 6m at 13.24gt Au 16 Dec 2022 8:16AM $0.320 $0.585 risen by 82.81%

501 - 525 of 905 results

Page 21 of 37

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.